Cuu Long Pharmaceutical

DCL

VN000000DCL1

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
29,300 ^VND	+0.34%		+1.03%	+17.20%

05-22	Cuu Long Pharmaceutical Joint Stock Company Announces Board Appointments	CI
04-24	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Cuu Long Pharmaceutical Joint Stock Company Appoints Vo Xuan Vinh as Deputy CEO

May 18, 2020 at 10:33 am

Cuu Long Pharmaceutical Joint Stock Company appointed Vo Xuan Vinh as Deputy CEO in charge of business as from May 15, 2020.

Latest news about Cuu Long Pharmaceutical

Cuu Long Pharmaceutical Joint Stock Company Announces Board Appointments	05-22	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Management Resignations	04-05	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01-29	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2023	01-29	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Change in Personnel	23/10/23	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	27/07/23	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Cuu Long Pharmaceutical Joint Stock Company Announces the Resignation of Nghiem Xuan Truong as CFO	21/03/23	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	30/01/23	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	30/01/23	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	28/10/22	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Luong Trong Hai as Director	06/09/22	CI
Cuu Long Pharmaceutical Joint Stock Company Announces CEO Changes	06/09/22	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	28/07/22	CI
Cuu Long Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2022	16/06/22	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Nguyen Ngoc Vinh as Deputy CEO	05/05/22	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Cuu Long Pharmaceutical Joint Stock Company announced that it has received VND 355.20515 billion in funding	15/03/22	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2021	20/01/22	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	20/01/22	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Executive Changes	04/01/22	CI
Cuu Long Pharmaceutical Joint Stock Company announced a financing transaction	28/12/21	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Executive Changes	21/12/21	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Suspension of Operation of Branches	17/12/21	CI

Cuu Long Pharmaceutical Joint Stock Corporation (Pharimexco) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, markets and distributes pharmaceutical drugs and capsules, as well as medical equipment and supplies. It is also involved in the manufacture and trading of functional food, cosmetic products, chemicals and other materials for pharmaceutical production. Other activities include the manufacture of specialized packagings for drugs and medical products, as well as the cultivation of traditional herbs.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CUU LONG PHARMACEUTICAL	+17.20%	84.11M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B